Lloyd MacKenzie

Lloyd Mackenzie currently serves as the Chief Technical Operations Officer at Aspect Biosystems since September 2023. Previously, Mackenzie held various positions in the biotech sector, including Biotech Consultant at Novateur Ventures Inc. and President and Chief Operating Officer at Symvivo Corporation, where responsibilities included overseeing the development of oral DNA vaccines for serious diseases. Additional roles included Chief Operating Officer at NervGen Pharma Corp., Chief Development Officer at Notable, and multiple leadership positions at Aquinox Pharmaceuticals, Inc. Mackenzie's career began as a Research Scientist at Inflazyme Pharmaceuticals Ltd. and QLT Inc. Lloyd Mackenzie earned a Bachelor of Science in Biochemistry from Simon Fraser University.